Gastric adenocarcinoma burden and late‐stage diagnosis in Latino and non‐Latino populations in the United States and Texas, during 2004–2016: A multilevel analysis

In a recent trial in the United States a physician was convicted of manslaughter during the performance of a hysterotomy on a woman pregnant from twenty to twenty eight weeks. Some members of the jury, in their deliberations, were much impressed by seeing a photograph of a fetus of about the same age. The experience apparently provided some jurors with reason to conclude that the fetus which did die during or immediately after the hysterotomy was a human being or a person or, at least, was so like a child that the killing of it was prohibited by the law of homicide. If being a human being is not the same as being a pre-natal progeny of homo sapiens, it is difficult to understand how one could “tell by looking” whether the fetus is a human being. But the sight of a fetus of twenty weeks or longer does, I think, tempt us to think that from a moral standpoint we ought to extend the same treatment to such fetuses, or virtually the same, as we extend to newborn babies and young children. The visual similarities between middle or late stage fetuses and newborn babies is striking.

Download Full-text

Race/Ethnicity, Gender and Job Earnings across Metropolitan Areas in the United States: A Multilevel Analysis

Urban Studies ◽

10.1177/0042098007088470 ◽

2008 ◽

Vol 45 (4) ◽

pp. 825-843 ◽

Cited By ~ 19

Author(s):

Qingfang Wang

Keyword(s):

United States ◽

Multilevel Analysis ◽

Metropolitan Areas ◽

The United States ◽

Race Ethnicity

Download Full-text

Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States

Gastric Cancer ◽

10.1007/s10120-018-0826-x ◽

2018 ◽

Vol 21 (6) ◽

pp. 889-899 ◽

Cited By ~ 3

Author(s):

Brian De ◽

Ryan Rhome ◽

Vikram Jairam ◽

Umut Özbek ◽

Randall F. Holcombe ◽

...

Keyword(s):

United States ◽

Young Adult ◽

Gastric Adenocarcinoma ◽

The United States ◽

Adult Patients ◽

Patterns Of Care

Download Full-text

The role of ingroup assortative sociality in the COVID-19 pandemic: A multilevel analysis of google trends data in the United States

International Journal of Intercultural Relations ◽

10.1016/j.ijintrel.2021.07.010 ◽

2021 ◽

Vol 84 ◽

pp. 168-180

Author(s):

Mac Zewei Ma ◽

Shengquan Ye

Keyword(s):

United States ◽

Multilevel Analysis ◽

The United States ◽

Google Trends

Download Full-text

Current landscape of prostate cancer quality measures in the United States.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.7_suppl.273 ◽

2016 ◽

Vol 34 (7_suppl) ◽

pp. 273-273

Author(s):

Scott C Flanders ◽

Eleanor Fitall ◽

Dayo Jagun ◽

Kristi Mitchell ◽

Peter St. John Francis ◽

...

Keyword(s):

Prostate Cancer ◽

United States ◽

Risk Stratification ◽

Late Stage ◽

Symptom Assessment ◽

Quality Measures ◽

The United States ◽

Additional Treatment ◽

Urological Surgery ◽

The Us

273 Background: Prostate cancer (PCa) is the leading cancer for men in the United States (US) and identified by the Centers for Medicare & Medicaid Services (CMS) as one of the top 20 high-impact Medicare conditions experienced by beneficiaries. Thus, there is increasing focus by stakeholders to measure and achieve high-value, quality care in PCa. However, quality measurement is particularly difficult in oncology. Our aim was to assess the current landscape of PCa quality measures (QMs) in the US. Methods: Published literature and online resources from the past 5 years were reviewed to identify PCa QMs and general oncology QMs relevant to PCa. PCa QMs were categorized using a “continuum of care” framework across 5 stages: 1) symptom assessment and screening; 2) diagnosis and risk stratification; 3) initial treatment; 4) monitoring and additional treatment; and 5) advanced- or late-stage care. Finally, PCa QMs were evaluated for their type (eg. process, outcomes), and use by CMS. Results: We identified 16 PCa-specific QMs and 20 general oncology QMs relevant to PCa. The majority of PCa QMs were developed by the American Medical Association–Physician Consortium for Performance Improvements (6 measures) and the Michigan Urological Surgery Improvement Collaborative (6 measures). There are 3 QMs for symptom assessment and screening, 5 QMs for diagnosis and risk stratification, 6 QMs for initial treatment, 2 QMs for monitoring and additional treatment, and 0 QMs for advanced- or late-stage care. Fourteen PCa QMs focus on process of care, but only 2 PCa QMs address outcomes. Nine PCa QMs are part of CMS quality improvement programs, 6 of which are reportable through the Michigan Urological Surgery Improvement Collaborative. Three new PCa QMs are under consideration by CMS. Conclusions: We found few PCa QMs that capture outcomes of patient experience or care, and no PCa-specific QMs available for advanced disease and late-stage care, demonstrating a need to better define quality in this setting. Opportunities to increase the focus on innovative, real-world data-generation strategies, such as PCa disease registries that collect clinical outcomes, patient preferences, and comorbidities, may inform stakeholder development and adoption of new QMs in the US.

Download Full-text

Racial disparities in the presentation of hepatocellular carcinoma in the population 65+ years in the United States.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.4_suppl.249 ◽

2018 ◽

Vol 36 (4_suppl) ◽

pp. 249-249

Author(s):

Michael Ross Kaufman ◽

David J. Delgado ◽

Stephanie Costa ◽

Brandon George ◽

Edith P. Mitchell

Keyword(s):

United States ◽

Hepatocellular Carcinoma ◽

Racial Disparities ◽

Late Stage ◽

The United States ◽

Pacific Islanders ◽

Stage Iii ◽

Ajcc Stage ◽

Asian Pacific Islanders ◽

Asian Pacific

249 Background: Insufficient evidence exists regarding the presentation and management of elderly patients with hepatocellular carcinoma (HCC). The purpose of this study was to describe racial differences in cancer staging of elderly (65+) patients with HCC diagnosed in the United States. Methods: A retrospective cohort study was conducted using the 1973-2014 Surveillance, Epidemiology and End Results Program (SEER) database of the National Cancer Institute. Patients with primary hepatocellular carcinoma, diagnosed between 2004 and 2014, and with complete information on race, gender, year of diagnosis, age, marital status, region and stage at diagnosis (Derived SEER Summary Stage 2000, and Derived American Joint Committee on Cancer (AJCC) Stage Group, 6th Edition) were included. Descriptive statistics were used to compare sociodemographic and clinical variables with race. Univariate and multivariate logistic regressions were preformed to describe the association of race with the diagnosis of late stage HCC (Regional/Distant vs Localized Stage for SEER Summary Stage, and Stage III/IV vs Stage I/II for AJCC Stage Group). Results: The sample consisted of 19,902 HCC patients: 69.7% White, 9.2% Black, 20.2% API, 1.0% AI; 69.1% male; 45.1% diagnosed in 2004-2009; 56.2% age 65-74, 35.6% 75-84, and 8.2% 85 and older; 58.3% married; 7.4% Midwest, 12.4% Northeast, 17.0% Southeast, 63.2% Pacific West; 44.9% Regional/Distant Stage (SEER Summary Stage) and 41.2% Stage III/IV (AJCC Stage Group). After controlling for confounding variables, Asian/Pacific Islanders had a decreased odds of presenting with late stage disease relative to whites in both the SEER Summary Stage (OR: 0.867, CI:0.805-0.934) and AJCC Stage Group (OR: 0.904, CI:0.838-0.975). Conclusions: Racial disparities exist at the presentation of HCC in the 65+ population. Asian/Pacific Islanders are less likely to be diagnosed with late stage HCC compared to whites. There is a need to study further these relationships in subpopulations.

Download Full-text